University of Tasmania

File(s) under permanent embargo

Association of Metallothionein-III with Oligodendroglial Cytoplasmic Inclusions in Multiple System Atrophy

journal contribution
posted on 2023-05-17, 07:22 authored by Pountney, DL, Tracey DicksonTracey Dickson, Power, JHT, James VickersJames Vickers, Adrian WestAdrian West, Gai, WP
Multiple system atrophy (MSA) is an adultonset neurodegenerative disease characterised by Parkinsonian and autonomic symptoms and by widespread intracytoplasmic inclusion bodies in oligodendrocytes. These glial cytoplasmic inclusions (GCIs) are comprised of 9–10 nm filaments rich in the protein alpha-synuclein, also found in neuronal inclusion bodies associated with Parkinson’s disease. Metallothioneins (MTs) are a class of low-molecular weight (6–7 kDa), cysteine-rich metalbinding proteins the expression of which is induced by heavy metals, glucocorticoids, cytokines and oxidative stress. Recent studies have shown a role for the ubiquitously expressed MT-I/II isoforms in the brain following a variety of stresses, whereas, the function of the brain-specific MT isoform, MT-III, is less clear. MT-III and MT-I/II immunostaining of post-mortem tissue in MSA and normal control human brains showed that the number of MT-IIIpositive cells is significantly increased in MSA in visual cortex, whereas MT-I/II isoforms showed no significant difference in the distribution of immunopositive cells in MSA compared to normal tissue. GCIs were immunopositive for MT-III, but were immunonegative for the MT-I/II isoforms. Immunofluorescence double labelling showed the co-localisation of alpha-synuclein and MT-III in GCIs in MSA tissue. In isolated GCIs, transmission electron microscopy demonstrated MT-III immunogold labelling of the amorphous material surrounding alpha-synuclein filaments in GCIs. High-molecular weight MT-III species in addition to MT-III monomer were detected in GCIs by Western analysis of the detergent-solubilised proteins of purified GCIs. These results show that MT-III, but not MTI/ II, is a specific component of GCIs, present in abnormal aggregated forms external to the alpha-synuclein filaments.


Publication title

Neurotoxicity Research: An International Journal on Processes and Mechanisms in Neurodegeneration, Apoptosis, Neuroprotection and Regeneration








Menzies Institute for Medical Research


F P Graham Publishing Co

Place of publication

Po Box 370, Mountain Home, USA, Tn, 37684

Rights statement

Copyright © Springer Science+Business Media, LLC 2009 The final publication is available at

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania


    Ref. manager